Watch they'll announce the spilt after hours to be in effect within a couple days.Why wait they could careless about current shareholders.Free has been a scam from its start.
Sure they would, if results aren't good this stock will be at .60 cents in a hurry.Better raise 10 million now at 1.25 then 30-40 later if results arent good.If results are good they will likely be at 3-4 then they can do another offer to fill the bank.
At least your coming out of the kool-ade induced stupor . Shorts have zero reason to cover gevo and in fact more of a reason to press the bet.Heres why, They know a very large share offer is coming.Gevo the piggy bank needs to be filled again. Large investors also will not pony up at these prices .Why to much risk but maybe around 1.00 they would be players.Shorts also can get in on the share offer and cover all their bets in one block scoop off market in the offer.Watch and learn folks
Pucker up gevo butter cups then next drop is coming.SNGX slow and steady as the up listing to the nasdaq/amex comes.BSPM just started its new move today.Will be riding that one to the 2s
no wonder you clowns did so bad with the scam gevo.You guys can't do DD. Kirk owns 31.9% .Have a look at the SEC filings and guess you see they do have the funding i said they had.Gevo only wishes they could get such huge non dilutive funding.Good news is the next contract is coming.Sngx is heading north baby!
On Sept. 25, 2013, Soligenix, Inc. (OTC BB:SNGX) announced that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (NIH) (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
The NIAID contract is awarded for the advanced preclinical development of OrbeShield™ (oral beclomethasone 17,21-dipropionate or oral BDP) as a biodefense medical countermeasure (MCM) for the treatment of gastrointestinal acute radiation syndrome (GI ARS).
This is a contract for three years which contains a one year base period, with two contract options that would extend the contract an additional year each. The total award will support the development activities necessary to evaluate OrbeShield™ as a potential MCM to treat GI ARS.
This is the second government contract Soligenix secured within one week. Last week, Soligenix was awarded a $26.3 million contract by the US Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA). Both contracts are awarded for the advanced preclinical and manufacturing development of OrbeShield™ as a biodefense medical countermeasures (MCMs) for the treatment of gastrointestinal acute radiation syndrome (GI ARS).
SNGX is the bio to be in.Watch it and that me later . Randal Kirk of Intrexon bought a big stake in them.the have over 30 million in non dilutive funding. As for cvm well we now they are a dilution machine!
Looks like their back in compliance again, not to mention when earnings come out and their still growing like the last quarter this stock will be over 2.00s in a hurry
SNGX is heading for a new break out which will but it in a big gap area. Watch 2.48 then 2.54 after will talk at 3.50.Company has over 30 million in non dilutive funding and is waiting on another contract that will give them more funding.Randal Kirk of Intrexon has taken a large stake in them.This bio is bigtime under valued.Gevo oh well enjoy the dead cat before the next big drop into a major dilution share offer.